Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Milton S. Hershey Medical Center
Milton S. Hershey Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Spanish Lung Cancer Group
Kura Oncology, Inc.
Kura Oncology, Inc.
Kura Oncology, Inc.
Samsung Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Lymphoma Study Association
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
National Cancer Institute (NCI)
NYU Langone Health
H. Lee Moffitt Cancer Center and Research Institute
The University of Texas Health Science Center at San Antonio
SWOG Cancer Research Network
Mayo Clinic
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
University of Bologna
Institut Claudius Regaud